Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigating the Significance of Protein Biomarkers During the Hyperacute Phase of Traumatic Brain Injury and Other CNS Conditions With Hypoxia/Hypoperfusion in Emergency and Prehospital Settings (CHARON)

NCT07782216 is registered in ClinicalTrials.gov with University of Pecs as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07782216 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigating the Significance of Protein Biomarkers During the Hyperacute Phase of Traumatic Brain Injury and Other CNS Conditions With Hypoxia/Hypoperfusion in Emergency and Prehospital Settings (CHARON)
Lead sponsor
University of Pecs
Phase
Observational
Overall status
Recruiting
Start date
March 1, 2026
Completion date
December 31, 2028
Enrollment
477 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

brain injuries, acute, brain injuries, traumatic, cardiac arrest (ca), hypoxia, brain